Literature DB >> 8864140

Differential screening identifies genetic markers of monocyte to macrophage maturation.

S W Krause1, M Rehli, M Kreutz, L Schwarzfischer, J D Paulauskis, R Andreesen.   

Abstract

Maturation of cells of the mononuclear phagocyte lineage from bone marrow precursors to tissue macrophages (MAC) via circulating blood monocytes (MO) is a multistep process only partially understood. Similarly, MAC differentiation can be observed if MO are cultured in vitro. In an attempt to further characterize molecular changes occurring during this process we carried out differential screening of a MO-derived MAC cDNA library using MO and MAC cDNA. After subcloning and confirmation by a second round of screening, partial sequencing of 41 cDNA clones was performed. In 33 clones the sequences of 7 different previously identified cDNAs were found. The mRNA expression of two of the corresponding genes (apolipoprotein E, ferritin light chain) is already known to be up-regulated during MAC maturation. For one gene (cathepsin B), a specific up-regulation of mRNA expression could be shown corresponding to previous protein data. For four genes [human cartilage glycoprotein (HC-gp39), osteopontin, type IV collagenase, and tryptophanyl-tRNA synthetase] the specific expression in MAC versus MO was previously unknown but could be confirmed by the use of Northern blot analysis. Of these genes, HC-gp39 is especially interesting because it is only expressed during the late stages of MAC differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864140     DOI: 10.1002/jlb.60.4.540

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  57 in total

1.  Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: identity with CD84.

Authors:  S W Krause; M Rehli; S Heinz; R Ebner; R Andreesen
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation.

Authors:  Dafna Bonneh-Barkay; Stephanie J Bissel; Julia Kofler; Adam Starkey; Guoji Wang; Clayton A Wiley
Journal:  Brain Pathol       Date:  2011-12-22       Impact factor: 6.508

Review 3.  New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma.

Authors:  Daniel Elieh Ali Komi; Tohid Kazemi; Anton Pieter Bussink
Journal:  Curr Allergy Asthma Rep       Date:  2016-08       Impact factor: 4.806

Review 4.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 5.  Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.

Authors:  Katrin Eurich; Mayuko Segawa; Satoko Toei-Shimizu; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

6.  A conceptual cellular interaction model of left ventricular remodelling post-MI: dynamic network with exit-entry competition strategy.

Authors:  Yunji Wang; Hai-Chao Han; Jack Y Yang; Merry L Lindsey; Yufang Jin
Journal:  BMC Syst Biol       Date:  2010-05-28

7.  Role of breast regression protein-39/YKL-40 in asthma and allergic responses.

Authors:  Chun Geun Lee; Jack A Elias
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

8.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

9.  Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets.

Authors:  Petronela Ancuta; Kuang-Yu Liu; Vikas Misra; Vanessa Sue Wacleche; Annie Gosselin; Xiaobo Zhou; Dana Gabuzda
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

Review 10.  YKL-40--an emerging biomarker in cardiovascular disease and diabetes.

Authors:  Camilla N Rathcke; Henrik Vestergaard
Journal:  Cardiovasc Diabetol       Date:  2009-11-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.